These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 19703607

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
    Tuñón J, Ruiz-Moreno JM, Martín-Ventura JL, Blanco-Colio LM, Lorenzo O, Egido J.
    Surv Ophthalmol; 2009; 54(3):339-48. PubMed ID: 19422962
    [Abstract] [Full Text] [Related]

  • 3. Ranibizumab for neovascular age-related macular degeneration.
    Gillies MC, Wong TY.
    N Engl J Med; 2007 Feb 15; 356(7):748-9; author reply 749-50. PubMed ID: 17310523
    [No Abstract] [Full Text] [Related]

  • 4. Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
    Querques G.
    Am J Ophthalmol; 2009 Feb 15; 147(2):375-6; author reply 376-7. PubMed ID: 19166716
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy in the anti-VEGF era.
    Fine HF.
    Br J Ophthalmol; 2007 Jun 15; 91(6):707-8. PubMed ID: 17510474
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy for age-related macular degeneration.
    Patel S.
    Retina; 2009 Jun 15; 29(6 Suppl):S45-8. PubMed ID: 19553801
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Strategies for inhibiting vascular endothelial growth factor.
    Kaiser PK.
    Retina; 2009 Jun 15; 29(6 Suppl):S15-7. PubMed ID: 19553789
    [Abstract] [Full Text] [Related]

  • 10. Pathology beyond neovascularization: new targets in age-related macular degeneration.
    Heier JS.
    Retina; 2009 Jun 15; 29(6 Suppl):S39-41. PubMed ID: 19553799
    [Abstract] [Full Text] [Related]

  • 11. Antiangiogenic approaches to age-related macular degeneration today.
    Bressler NM.
    Ophthalmology; 2009 Oct 15; 116(10 Suppl):S15-23. PubMed ID: 19800535
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
    Ciulla TA, Rosenfeld PJ.
    Curr Opin Ophthalmol; 2009 May 15; 20(3):166-74. PubMed ID: 19381089
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L, Ruiz-Moreno JM, Gómez-Ulla F, Fernández M, Montero J.
    Retina; 2009 May 15; 29(10):1444-9. PubMed ID: 19730163
    [Abstract] [Full Text] [Related]

  • 19. Rationale for combination therapy in age-related macular degeneration.
    Spaide RF.
    Retina; 2009 Jun 15; 29(6 Suppl):S5-7. PubMed ID: 19553803
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.